If lowering your dose does not resolve issues, professional evaluation helps rule out other causes and determine if continuing is appropriate
In SURMOUNT-1, 72 weeks of tirzepatide induced mean WL of 1622.5% in people without diabetes compared to 2.4% with placebo, with no sign of the weight plateauing, suggesting that there may be further WL with long-term use [46]
This protocol has since been adapted with direct differentiation of iPSC to brain endothelial cells using a chemically defined medium (Qian et al., 2017)
The rationale is that TRT stabilizes systemic testosterone while BPC 157 supports tissue healing and vascular health, potentially mitigating training-related injuries and TRT-linked blood pressure changes
doi: 10.3389/fncel.2020.618986 72 SweeneyM
Supports Longevity & Healthy Aging: By preserving telomere length, Epithalon may slow cellular aging and support a longer healthspan